Buy One Get One free -Llimited Time Offer X
Meganeuron PG is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Meganeuron PG safe for pregnant women?
Pregnant women can take Meganeuron PG without worrying about any side effects.
Is the use of Meganeuron PG safe during breastfeeding?
Meganeuron PG is safe for breastfeeding women.
What is the effect of Meganeuron PG on the Kidneys?
Very few cases of side effects of Meganeuron PG on kidney have been reported.
What is the effect of Meganeuron PG on the Liver?
Meganeuron PG may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Meganeuron PG on the Heart?
There is no research available on the side effects of Meganeuron PG on the heart. Therefore, its impact is unknown.
Meganeuron PG should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Meganeuron PG unless your doctor advises you to do so -
Is this Meganeuron PG habit forming or addictive?
Meganeuron PG does not cause addiction.
Interaction between Food and Meganeuron PG
Taking Meganeuron PG with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Meganeuron PG
No research has been done on this till date. Therefore, it is not known what the effect of taking Meganeuron PG with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 609-611
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420